These results indicate that the inhibitory effects of Trim44 KO on ISO-induced pathological myocardial hypertrophy were achieved, at least in part, through inhibition of the AKT/mTOR signaling pathway. The gene discussed is TRIM44; the disease is cardiac hypertrophy.